Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker
119th CongressS. 5127

Introduced in Senate

Harley Jacobsen Clinical Trial Participant Income Exemption Act of 2026

SEC. 1. SHORT TITLETrack this section →

This Act may be cited as the Harley Jacobsen Clinical Trial Participant Income Exemption Act of 2026.

SEC. 2. EXCLUSION OF COMPENSATION PROVIDED TO PARTICIPANTS IN CLINICAL TRIALSTrack this section →

(a) In general Part III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after section 139L the following new section: 139M. Clinical trial payments (a) In general Gross income shall not include any amount received by an individual as a qualified clinical trial payment. (b) Qualified clinical trial payment defined For purposes of this section, the term qualified clinical trial payment means any amount paid to an individual— (1) as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or (2) to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial. (c) Other definitions For purposes of this section— (1) Approved clinical trial The term approved clinical trial has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by substituting disease or condition for life-threatening disease or condition. (2) Dependent The term dependent has the meaning given such term in section 152.. (b) Clerical amendment The table of sections for part III of subchapter B of chapter 1 of such Code is amended by inserting after the item relating to section 139L the following new item: Sec. 139M. Clinical trial payments.. (c) Effective date The amendments made by this section shall apply to amounts paid after December 31, 2025.

SEC. 3. CLINICAL TRIAL COMPENSATION NOT TAKEN INTO ACCOUNT FOR PURPOSES OF DETERMINING ELIGIBILITY FOR FEDERAL PROGRAMS OR ASSISTANCETrack this section →

(a) In general Notwithstanding any other provision of law, any amount received by an individual as a qualified clinical trial payment shall not be taken into account as income or resources for purposes of determining the eligibility of such individual (or any other individual) for benefits or assistance (or the amount or extent of benefits or assistance) under any Federal program or under any State or local program financed in whole or in part with Federal funds. (b) Qualified clinical trial payment For purposes of subsection (a), the term qualified clinical trial payment has the meaning given such term in section 139M(b) of the Internal Revenue Code of 1986 (as added by section 2 of this Act).

•S 5127 ISText from GovInfo